Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Sylva Helanova"'
Autor:
Raymond S. McDermott, John Greene, John McCaffrey, Imelda Parker, Sylva Helanova, Anne-Marie Baird, Ausra Teiserskiene, Marvin Lim, Helen Matthews, Olwyn Deignan, John Feeney, Pierre G. Thirion, Stephen P. Finn, Paul J. Kelly
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 13 (2021)
Background: Radium-223 and enzalutamide are approved agents for patients with metastatic castration-resistant prostate cancer (mCRPC). Combining radium-223 and enzalutamide to improve outcomes is of clinical interest due to their differing modes of a
Externí odkaz:
https://doaj.org/article/9ecf3e519d8642928d0b391548f30aa3
Autor:
Pierre Thirion, Paul J. Kelly, Helen Matthews, Anne-Marie Baird, Raymond S. McDermott, John Feeney, Olwyn Deignan, John Greene, Ausra Teiserskiene, John McCaffrey, Imelda Parker, Stephen P. Finn, Sylva Helanova, Marvin Lim
Publikováno v:
Therapeutic Advances in Medical Oncology
Therapeutic Advances in Medical Oncology, Vol 13 (2021)
Therapeutic Advances in Medical Oncology, Vol 13 (2021)
Background: Radium-223 and enzalutamide are approved agents for patients with metastatic castration-resistant prostate cancer (mCRPC). Combining radium-223 and enzalutamide to improve outcomes is of clinical interest due to their differing modes of a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::41363785c4d79994afcc34a784ba8faf
http://europepmc.org/articles/PMC8427915
http://europepmc.org/articles/PMC8427915